Literature DB >> 27625339

Antifungal susceptibility testing of Malassezia yeast: comparison of two different methodologies.

Florencia D Rojas1, Susana B Córdoba2, María de Los Ángeles Sosa1, Laura C Zalazar3, Mariana S Fernández1, María E Cattana1, Liliana R Alegre1, Alfonso J Carrillo-Muñoz4, Gustavo E Giusiano1.   

Abstract

All Malassezia species are lipophilic; thus, modifications are required in susceptibility testing methods to ensure their growth. Antifungal susceptibility of Malassezia species using agar and broth dilution methods has been studied. Currently, few tests using disc diffusion methods are being performed. The aim was to evaluate the in vitro susceptibility of Malassezia yeast against antifungal agents using broth microdilution and disc diffusion methods, then to compare both methodologies. Fifty Malassezia isolates were studied. Microdilution method was performed as described in reference document and agar diffusion test was performed using antifungal tablets and discs. To support growth, culture media were supplemented. To correlate methods, linear regression analysis and categorical agreement was determined. The strongest linear association was observed for fluconazole and miconazole. The highest agreement between both methods was observed for itraconazole and voriconazole and the lowest for amphotericin B and fluconazole. Although modifications made to disc diffusion method allowed to obtain susceptibility data for Malassezia yeast, variables cannot be associated through a linear correlation model, indicating that inhibition zone values cannot predict MIC value. According to the results, disc diffusion assay may not represent an alternative to determine antifungal susceptibility of Malassezia yeast.
© 2016 Blackwell Verlag GmbH.

Entities:  

Keywords:  disc diffusion; lipid-dependent yeast; minimal inhibitory concentration

Mesh:

Substances:

Year:  2016        PMID: 27625339     DOI: 10.1111/myc.12556

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  7 in total

1.  In Vitro Azole and Amphotericin B Susceptibilities of Malassezia furfur from Bloodstream Infections Using E-Test and CLSI Broth Microdilution Methods.

Authors:  Wafa Rhimi; Chioma Inyang Aneke; Adriana Mosca; Domenico Otranto; Claudia Cafarchia
Journal:  Antibiotics (Basel)       Date:  2020-06-26

2.  Genomic Multiplication and Drug Efflux Influence Ketoconazole Resistance in Malassezia restricta.

Authors:  Minji Park; Yong-Joon Cho; Yang Won Lee; Won Hee Jung
Journal:  Front Cell Infect Microbiol       Date:  2020-04-30       Impact factor: 5.293

3.  Antifungal activity of silver nanoparticles in combination with ketoconazole against Malassezia furfur.

Authors:  Javier Esteban Mussin; María Virginia Roldán; Florencia Rojas; María de Los Ángeles Sosa; Nora Pellegri; Gustavo Giusiano
Journal:  AMB Express       Date:  2019-08-20       Impact factor: 3.298

Review 4.  Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals.

Authors:  Stefan Hobi; Claudia Cafarchia; Valentina Romano; Vanessa R Barrs
Journal:  J Fungi (Basel)       Date:  2022-07-04

5.  In Vitro Assessment of Azole and Amphotericin B Susceptibilities of Malassezia spp. Isolated from Healthy and Lesioned Skin.

Authors:  Wissal Chebil; Najoua Haouas; Elja Eskes; Paul Vandecruys; Sameh Belgacem; Hichem Belhadj Ali; Hamouda Babba; Patrick Van Dijck
Journal:  J Fungi (Basel)       Date:  2022-09-13

Review 6.  Malassezia-Associated Skin Diseases, the Use of Diagnostics and Treatment.

Authors:  Ditte M L Saunte; George Gaitanis; Roderick James Hay
Journal:  Front Cell Infect Microbiol       Date:  2020-03-20       Impact factor: 5.293

7.  Malassezia restricta Pneumonia in Solid Organ Transplant Recipients: First Report of Two Cases.

Authors:  Alessandra Mularoni; Elena Graziano; Alice Annalisa Medaglia; Barbara Buscemi; Taylor Eddens; Lavinia Martino; Daniele Di Carlo; Antonio Cascio; Pier Giulio Conaldi; Alessandro Bertani; Paolo Antonio Grossi
Journal:  J Fungi (Basel)       Date:  2021-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.